Scientists may have stumbled onto a new way to treat depression:an experimental drug that targets a mysterious brain chemical that doctors did not know was at work in mental disorders. Merck & Co.'s drug, the subject of an account published in Science, works on a chemical pathway that differs from every antidepressant sold today and offers hope to patients who get no help from standard therapies.